SCL - Stepan Company
NYSE
->
Basic Materials
->
Specialty Chemicals
Northbrook,
United States
Type: Equity
SCL price evolution
SCL
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $124.71 | $125.78 | $129.82 | |
| Short term investments | ||||
| Net receivables | $434.15 | $437.35 | $446.57 | $422.05 |
| Inventory | $296.7 | $266.01 | $257.12 | $265.56 |
| Total current assets | $918.16 | $867.14 | $869.81 | $851.88 |
| Long term investments | $24.08 | $23.47 | $26.8 | |
| Property, plant & equipment | $1271.09 | $1264.25 | $1277.12 | $1277.31 |
| Goodwill & intangible assets | $142.03 | $146.87 | $150.01 | |
| Total noncurrent assets | $1481.45 | $1503.34 | $1511.47 | |
| Total investments | $24.08 | $23.47 | $26.8 | |
| Total assets | $2413.79 | $2348.59 | $2373.15 | $2363.35 |
| Current liabilities | ||||
| Accounts payable | $257.07 | $251.19 | $256.88 | $233.03 |
| Deferred revenue | ||||
| Short long term debt | $282.35 | $245.86 | $252.9 | |
| Total current liabilities | $721.29 | $655.2 | $628.85 | $607.87 |
| Long term debt | $348.67 | $431.37 | $459.18 | $459.27 |
| Total noncurrent liabilities | $500.96 | $529.77 | $538.99 | |
| Total debt | $713.72 | $705.04 | $712.17 | |
| Total liabilities | $1194.42 | $1156.15 | $1158.63 | $1146.86 |
| Shareholders' equity | ||||
| Retained earnings | $1279.2 | $1264.03 | $1262.94 | $1257.47 |
| Other shareholder equity | -$151.72 | -$161.9 | -$136.27 | -$130.6 |
| Total shareholder equity | $1192.44 | $1214.52 | $1216.49 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $129.82 | $173.75 | $159.19 | $349.94 |
| Short term investments | ||||
| Net receivables | $422.05 | $436.91 | $419.54 | $301.32 |
| Inventory | $265.56 | $402.53 | $305.54 | $218.78 |
| Total current assets | $851.88 | $1044.8 | $913.37 | $905.65 |
| Long term investments | $26.8 | $23.29 | $34.49 | $30.65 |
| Property, plant & equipment | $1277.31 | $1135.84 | $920.22 | $745.09 |
| Goodwill & intangible assets | $150.01 | $153.95 | $157.97 | $52.04 |
| Total noncurrent assets | $1511.47 | $1388.37 | $1152.24 | $846.68 |
| Total investments | $26.8 | $23.29 | $34.49 | $30.65 |
| Total assets | $2363.35 | $2433.17 | $2065.61 | $1752.34 |
| Current liabilities | ||||
| Accounts payable | $233.03 | $375.73 | $323.36 | $236.75 |
| Deferred revenue | ||||
| Short long term debt | $252.9 | $132.11 | $40.72 | $37.86 |
| Total current liabilities | $607.87 | $670.65 | $500.48 | $416.55 |
| Long term debt | $459.27 | $455.03 | $379.53 | $212.38 |
| Total noncurrent liabilities | $538.99 | $596.46 | $490.94 | $347.42 |
| Total debt | $712.17 | $637.7 | $420.25 | $250.24 |
| Total liabilities | $1146.86 | $1267.11 | $991.42 | $763.97 |
| Shareholders' equity | ||||
| Retained earnings | $1257.47 | $1250.13 | $1133.55 | $1023.83 |
| Other shareholder equity | -$130.6 | -$167.51 | -$153.24 | -$136.88 |
| Total shareholder equity | $1216.49 | $1166.07 | $1074.19 | $986.69 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $546.84 | $556.4 | $551.42 | |
| Cost of revenue | $486.85 | $481.14 | ||
| Gross Profit | $75.69 | $69.55 | $70.28 | |
| Operating activities | ||||
| Research & development | $14.09 | $14.26 | ||
| Selling, general & administrative | $36.4 | $34.08 | ||
| Total operating expenses | $51.74 | $50.88 | $50.11 | |
| Operating income | $18.67 | $20.17 | ||
| Income from continuing operations | ||||
| EBIT | $19.87 | $22.53 | ||
| Income tax expense | -$2.29 | $7.68 | $5.57 | |
| Interest expense | -$3.62 | $2.66 | $3.07 | |
| Net income | ||||
| Net income | $23.61 | $9.52 | $13.89 | |
| Income (for common shares) | $9.52 | $13.89 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2325.77 | $2773.27 | $2345.97 | $1869.75 |
| Cost of revenue | $2048.17 | $2346.2 | $1950.16 | $1486.14 |
| Gross Profit | $277.6 | $427.07 | $395.81 | $383.61 |
| Operating activities | ||||
| Research & development | $59.04 | $66.63 | $62.69 | $57.99 |
| Selling, general & administrative | $141.57 | $161.21 | $152.09 | $142.91 |
| Total operating expenses | $218.99 | $219.73 | $225.03 | $212.09 |
| Operating income | $58.61 | $207.34 | $170.78 | $171.52 |
| Income from continuing operations | ||||
| EBIT | $60.49 | $198.51 | $178.2 | $175.59 |
| Income tax expense | $8.19 | $41.55 | $34.64 | $43.41 |
| Interest expense | $12.1 | $9.81 | $5.75 | $5.41 |
| Net income | ||||
| Net income | $40.2 | $147.15 | $137.8 | $126.77 |
| Income (for common shares) | $40.2 | $147.15 | $137.8 | $126.77 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $9.52 | $13.89 | -$1.19 | |
| Operating activities | ||||
| Depreciation | $28.01 | $27.6 | $27.02 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.56 | $1.37 | $2.06 | |
| Total cash flows from operations | $29.5 | $41.55 | $68.98 | |
| Investing activities | ||||
| Capital expenditures | -$29.71 | -$30.16 | -$46.74 | |
| Investments | ||||
| Total cash flows from investing | -$80.74 | -$29.62 | -$24.41 | -$46.74 |
| Financing activities | ||||
| Dividends paid | -$25.29 | -$8.43 | -$8.42 | -$8.39 |
| Sale and purchase of stock | ||||
| Net borrowings | $11.51 | -$8.41 | $4.43 | |
| Total cash flows from financing | $6.93 | $3.98 | -$19.98 | -$3.35 |
| Effect of exchange rate | -$2.5 | -$4.93 | -$1.2 | $5.43 |
| Change in cash and equivalents | $17.46 | -$1.07 | -$4.05 | $24.32 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $40.2 | $147.15 | $137.8 | $126.77 |
| Operating activities | ||||
| Depreciation | $105.34 | $94.65 | $90.88 | $81.86 |
| Business acquisitions & disposals | -$9.69 | -$183.83 | -$15.56 | |
| Stock-based compensation | $5.74 | $13.85 | $11.72 | $10.08 |
| Total cash flows from operations | $174.88 | $160.76 | $72.14 | $235.22 |
| Investing activities | ||||
| Capital expenditures | -$260.33 | -$301.55 | -$194.48 | -$125.79 |
| Investments | ||||
| Total cash flows from investing | -$258.67 | -$308.09 | -$376.83 | -$139.03 |
| Financing activities | ||||
| Dividends paid | -$32.87 | -$30.57 | -$28.08 | -$25.41 |
| Sale and purchase of stock | -$24.95 | -$16.97 | -$15.25 | |
| Net borrowings | $66.86 | $223.69 | $165 | -$23.57 |
| Total cash flows from financing | $33.28 | $166.21 | $117.33 | -$64.93 |
| Effect of exchange rate | $6.58 | -$4.32 | -$3.39 | $3.31 |
| Change in cash and equivalents | -$43.93 | $14.56 | -$190.75 | $34.55 |
News
Fundamentals
| Market cap | $1.51B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 22.49M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -2.74% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.94 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.27 |
| Quick ratio | 0.86 |